Heparin
Heparin Sodium (heparin) is an unknown pharmaceutical. It is marketed in the US. The pharmaceutical is active against antithrombin-III. In addition, it is known to target epidermal growth factor receptor, spike glycoprotein, and receptor tyrosine-protein kinase erbB-4.
| Trade Name | Heparin Sodium |
|---|---|
| Common Name | Heparin |
| Indication | cerebral infarction, coronary thrombosis, myocardial infarction, postoperative complications, pulmonary embolism, thromboembolism, thrombophlebitis, unstable angina |
| Drug Class |
